The top 3 holdings of LABU are EXACT Sciences (EXAS) (2.154%), Alnylam Pharmaceuticals (ALNY) (2.106%) and Neurocrine Biosciences (NBIX) (1.93%).

FUND	HOLDING	% OF FUND	VALUE ($)
LABU	EXACT Sciences (EXAS)	2.154%	$11.6M
LABU	Alnylam Pharmaceuticals (ALNY)	2.106%	$11.3M
LABU	Neurocrine Biosciences (NBIX)	1.93%	$10.4M
LABU	Natera (NTRA)	1.865%	$10M
LABU	United Therapeutics (UTHR)	1.776%	$9.6M
LABU	Incyte (INCY)	1.683%	$9.1M
LABU	Gilead Sciences (GILD)	1.655%	$8.9M
LABU	Blueprint Medicines (BPMC)	1.63%	$8.8M
LABU	Exelixis (EXEL)	1.613%	$8.7M
LABU	Biogen (BIIB)	1.592%	$8.6M
LABU	Insmed (INSM)	1.579%	$8.5M
LABU	Vertex Pharmaceuticals (VRTX)	1.549%	$8.3M
LABU	Amgen (AMGN)	1.538%	$8.3M
LABU	Regeneron Pharmaceuticals (REGN)	1.53%	$8.2M
LABU	AbbVie (ABBV)	1.521%	$8.2M
LABU	Moderna (MRNA)	1.349%	$7.3M
LABU	Madrigal Pharmaceuticals (MDGL)	1.337%	$7.2M
LABU	Biomarin Pharmaceutical (BMRN)	1.242%	$6.7M
LABU	BridgeBio Pharma (BBIO)	1.09%	$5.9M
LABU	Revolution Medicines (RVMD)	1.037%	$5.6M
LABU	TG Therapeutics (TGTX)	1.018%	$5.5M
LABU	Halozyme Therapeutics (HALO)	0.977%	$5.3M
LABU	Summit Therapeutics (SMMT)	0.968%	$5.2M
LABU	Ionis Pharmaceuticals (IONS)	0.959%	$5.2M
LABU	Crispr Therapeutics (CRSP)	0.896%	$4.8M

Holdings are tracked for approximately 2000 ETFs.